Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01227382 · ClinicalTrials.gov registry record · NA
Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods
A NA study of Pancreatic Duct Stricture and Accuracy of Tissue Diagnosis, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT01227382 is a NA study of Pancreatic Duct Stricture and Accuracy of Tissue Diagnosis that has completed, run by University of Florida. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01227382, a NA study of Pancreatic Duct Stricture and Accuracy of Tissue Diagnosis, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are evaluating the use of a SpyBite biopsy forceps for tissue diagnosis when compared to standard biopsy techniques.
Conditions Studied
Interventions
- PROCEDURE ERCP with cholangiopancreatoscopy
Study Locations (1)
Florida
- Shands at UF Ensopcopy - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01227382
The ClinicalTrials.gov registry entry for NCT01227382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pancreatic Duct Stricture appearing as the primary indexed condition, and to 1 intervention - of which ERCP with cholangiopancreatoscopy is the first listed.
NCT01227382 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01227382 about?
NCT01227382 is a clinical study titled "Accuracy of Spybite Forceps When Compared to Conventional Sampling Methods". The investigators are evaluating the use of a SpyBite biopsy forceps for tissue diagnosis when compared to standard biopsy techniques.
What is the current status of trial NCT01227382?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2015-05.
What conditions does trial NCT01227382 study?
This clinical trial studies the following conditions: Pancreatic Duct Stricture, Accuracy of Tissue Diagnosis, Bile Duct Stricture.
What interventions are being tested in trial NCT01227382?
The interventions under investigation include: ERCP with cholangiopancreatoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01227382?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01227382 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Duct Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.